BioSpace News Archive

Press Releases

Scientific Industries to Host First Quarter Fiscal Year 2025 Financial Results Investor Call on May 14, 2025

May 12, 2025
·
2 min read
Press Releases

Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)

May 12, 2025
·
11 min read
Press Releases

Ensoma Announces FDA Clearance of IND Application for First In Vivo HSC-Directed Gene Insertion Therapy

May 12, 2025
·
4 min read
Press Releases

Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome

May 12, 2025
·
9 min read
Press Releases

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders

May 12, 2025
·
6 min read
Press Releases

ProMIS Neurosciences Announces First Quarter 2025 Financial Results

May 12, 2025
·
14 min read
Press Releases

Capsida Receives FDA IND Clearance for Its First-in-Class, IV-administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy

May 12, 2025
·
3 min read
Press Releases

Genascence Phase 1b DONATELLO Trial Evaluating Potential First-in-Class Gene Therapy for Knee Osteoarthritis (OA) Meets Primary Endpoint Showing GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms

May 12, 2025
·
6 min read
Press Releases

Collegium Announces $25 Million Accelerated Share Repurchase Program

May 12, 2025
·
5 min read
Press Releases

Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025

May 12, 2025
·
6 min read